Efficacy of cognitive pragmatic treatment in adults with schizophrenia

被引:1
|
作者
Muthu, Anusuya [1 ]
Nambi, Shanthi [2 ]
Krishnan, Raman [2 ]
Vijayaraghavan, Rajagopalan [3 ]
机构
[1] Saveetha Med Coll & Hosp, Dept Speech Language & Hearing Sci ENT, Chennai, Tamil Nadu, India
[2] Saveetha Med Coll & Hosp, Dept Psychiat, Chennai, Tamil Nadu, India
[3] Saveetha Inst Med & Tech Sci, Dept Res & Dev, Chennai, Tamil Nadu, India
关键词
Schizophrenia; cognitive pragmatic treatment; cognitive functioning; pragmatic language impairment; group therapy; social communication impairment; ANTIPSYCHOTIC MEDICATION; LANGUAGE; DEFICITS; EXPRESSION; THERAPY; SKILLS;
D O I
10.54905/disssi/v27i132/e100ms2828
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: The study aimed to evaluate the efficiency of cognitive-pragmatic treatment (CPT) in improving cognitive functions and pragmatic language abilities in adults with schizophrenia. Methods: 100 individuals with schizophrenia who fulfilled the inclusion criteria were assigned to control (n = 25) and experimental groups (n = 75). Experimental groups received CPT for 3 months, while the control group obtained only routine care. Individuals were tested both before and after the intervention to gauge their progress also 3 months post-intervention, a follow-up evaluation was carried out. Analyses employed parametric and non-parametric statistics. Results: The findings revealed significant variations among groups and tests (p<0.001), & interaction of groups with tests (p<0.001) on two-way Repeated Measures ANOVA. Both the post-test and the follow-up assessment indicated that the experimental group had significantly higher levels of pragmatic language skills and cognitive functioning than the control group. There has been no major influence of age, gender and illness duration on the treatment outcomes by three-way ANOVA. Conclusions: The present study showed that CPT improved pragmatic language communication skills & cognitive functioning in adults with schizophrenia.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Cognitive remediation for adults with schizophrenia: Does age matter?
    Corbera, Silvia
    Wexler, Bruce E.
    Poltorak, Ania
    Thime, Warren R.
    Kurtz, Matthew M.
    PSYCHIATRY RESEARCH, 2017, 247 : 21 - 27
  • [42] Influences of Aerobic Dance on Cognitive Performance in Adults with Schizophrenia
    Chen, Ming-De
    Kuo, Yu-Hsin
    Chang, Yen-Ching
    Hsu, Su-Ting
    Kuo, Chang-Chih
    Chang, Jyh-Jong
    OCCUPATIONAL THERAPY INTERNATIONAL, 2016, 23 (04) : 346 - 356
  • [43] Toxoplasma gondii seropositivity and cognitive function in adults with schizophrenia
    Veleva, Ivanka
    Stoychev, Kaloyan
    Stoimenova-Popova, Maya
    Stoyanov, Lyudmil
    Mineva-Dimitrova, Eleonora
    Angelov, Ivelin
    SCHIZOPHRENIA RESEARCH-COGNITION, 2022, 30
  • [44] Brexpiprazole for the Treatment of Schizophrenia in Adults: An Overview of Its Clinical Efficacy and Safety and a Psychiatrist's Perspective
    Watanabe, Yoshinori
    Yamada, Sakiko
    Otsubo, Tempei
    Kikuchi, Toshiaki
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5559 - 5574
  • [45] The efficacy of cognitive neurorehabilitation with RehaCom program in schizophrenia patients
    Mak, Monika
    Tybura, Piotr
    Bienkowski, Przemyslaw
    Karakiewicz, Beata
    Samochowiec, Jerzy
    PSYCHIATRIA POLSKA, 2013, 47 (02) : 213 - 223
  • [46] Efficacy of adjunctive donepezil for cognitive impairments in patients with schizophrenia
    Mazza, M.
    Pollice, R.
    Gaspari, V.
    Giosue, R.
    Fragkou, E.
    Roncone, R.
    Casacchia, M.
    CLINICA TERAPEUTICA, 2005, 156 (05): : 203 - 209
  • [47] CLINICAL EFFICACY OF CLOZAPINE IN THE TREATMENT OF SCHIZOPHRENIA
    MELTZER, HY
    ALPHS, LD
    BASTANI, B
    RAMIREZ, LF
    KWON, K
    PHARMACOPSYCHIATRY, 1991, 24 (02) : 44 - 45
  • [48] Melperone, an atypical antipsychotic drug, in the treatment of schizophrenia: dose-response analysis on effectiveness and tolerability, and efficacy for treatment-resistant schizophrenia and cognitive function
    Sumiyoshi, T
    Meltzer, HY
    Jayathilake, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 184 - 184
  • [49] Efficacy of aripiprazole in the treatment of adolescents with schizophrenia
    Nyilas, M.
    Forbes, A.
    McQuade, R.
    Owen, R.
    Cox, K.
    Carson, W. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S568 - S568
  • [50] EFFICACY OF LOXAPINE IN TREATMENT OF PARANOID SCHIZOPHRENIA
    BISHOP, MP
    SIMPSON, GM
    DUNNETT, CW
    KILTIE, H
    PSYCHOPHARMACOLOGY, 1977, 51 (02) : 107 - 115